It has been reported that DKK1 produced by myeloma cells inhibits osteoblast differentiation in vitro, and increased DKK1 levels in bone marrow plasma and peripheral blood correlate with the presence of lytic bone lesions in myeloma patients [20]. The gene discussed is DKK1; the disease is plasma cell myeloma.